Found 150 matching trials
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
PHASE3RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Location
Cancer Research Campaign Trials Unit-Birmingham (CRCTU)
Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer
PHASE2This randomized phase II trial is studying how well pazopanib hydrochloride...
Location
University of Chicago Comprehensive Cancer Center
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
PHASE2Asymptomatic patients with metastatic castrate resistant prostate cancer (m...
Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer
PHASE1The goal of this clinical research study is to learn the safety of adding 3...
Location
University of Texas MD Anderson Cancer Center
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
PHASE2This randomized phase II trial is studying bicalutamide, goserelin, or leup...
Location
Fairbanks Memorial Hospital
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
PHASE3RATIONALE: Hormones can stimulate the growth of prostate cancer cells. Horm...
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
PHASE1Following a radical prostatectomy and lymph node sampling, eligible patient...
Location
University of Kansas Medical Center
Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer
PHASE2This phase II trial studies how well apalutamide and gonadotropin-releasing...
Location
M D Anderson Cancer Center
Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
PHASE2The goal of this clinical research study is to find out how treatment with ...
Location
Multiple Locations
Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer
PHASE3RATIONALE: Androgens can cause the growth of prostate cancer cells. Luteini...
Location
The Jikei University School of Medicine